Strathspey Crown Holdings Group, LLC - Aug 11, 2023 Form 4 Insider Report for AEON Biopharma, Inc. (AEON)

Role
10%+ Owner
Signature
Strathspey Crown Holdings Group, LLC, By: /s/ Andrew Lusk, Attorney-in-Fact for Robert E. Grant, Manager of Strathspey Crown Holdings Group, LLC
Stock symbol
AEON
Transactions as of
Aug 11, 2023
Transactions value $
-$73,803,940
Form type
4
Date filed
8/14/2023, 04:10 PM
Previous filing
Jul 31, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AEON Class A Common Stock Sale -$73.8M -7.38M -78.41% $10.00 2.03M Aug 11, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Strathspey Crown Holdings Group, LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Reflects the disposition of shares of the Issuer's Class A Common Stock (the "Distributed Shares") by the Reporting Person in connection with the repurchase of certain of the Reporting Person's membership interests held by its members in exchange for, among other consideration, the Distributed Shares.
F2 In addition to the disposition of the Distributed Shares, the amount reflected includes a reduction in the Reporting Person's beneficial ownership by an additional 8,203 shares of the Issuer's Class A Common Stock to correct an inadvertent overstatement of such ownership by such amount in the Reporting Person's Form 3 filed with the Securities and Exchange Commission on July 31, 2023.